|
|
|
|
||||
Solostar Injection Pen Approved for DiabetesPrefilled with Apidra, a rapid-acting insulin |
||||
THURSDAY, Feb. 26 (HealthDay News) -- Sanofi-Aventis's Apidra (insulin glulisine) Solostar injection pen has been approved to treat diabetes, the company said Thursday in a news release. The disposable pen with rapid-acting insulin was approved for adults with type 2 diabetes and for children four years and older with type 1 diabetes. The device requires lower injection force than competing products, the drug maker said. More information The FDA has additional information about Apidra, a drug first approved in 2004. |
||||
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
|
||||
|
Health News Provided By:
 |
||||
 
|
